||Registry of biomedical companies:
[(]  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 476 active entries
PO Box 1869
Palmerston North, 4440
Phone: (64) 6 952 3800
Fax: (64) 6 952 3801
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
New Zealand Pharmaceuticals Ltd (NZP) manufactures biochemicals and carbohydrate-based pharmaceutical ingredients, especially cholic acid and deoxycholic acid, the tauro and glyco- conjugates and other derivatives of the bile acids and sugar-derivatives. NZP’s products are manufactured to customer requirements. NZP holds EDQM Certificates, Drug Master Files, a Medicines Licence and a biological products processing Licence. NZP-Dextra manufactures grams to tonnes of all of its products and has cGMP carbohydrate glycotherapeutic, nucleoside, glycolipid and neoglycoprotein intermediates and APIs. Included in the product range is an N-acetylmannosamine and sialic acid-based portfolio for flu drugs, cell surface engineering and other uses. Also prominent are the azasugars and iminosugars that are being developed as enzyme inhibitors. Through Dextra, www.DextraUK.com, NZP-Dextra can offer highly technical custom synthesis, contract Process Development and cGMP multi-step manufacturing of small molecules for pre-clinical and clinical trials and on to large scale. NZP is ranked in New Zealand’s Top 500 companies and exports over 95% of its products. Dextra is the global leader in carbohydrate chemistry.
Last update of this entry: January 11, 2012